Prestige Consumer Healthcare
PBH
#4244
Rank
NZ$4.65 B
Marketcap
NZ$96.79
Share price
0.51%
Change (1 day)
-31.21%
Change (1 year)

Earnings for Prestige Consumer Healthcare (PBH)

Earnings in 2025 (TTM): NZ$0.45 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current earnings are NZ$1.10 Billion. a decrease over its 2024 earnings that were of NZ$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prestige Consumer Healthcare from 2005 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.45 B-3.92%
2024 NZ$0.47 B-405.61%
2023 -NZ$0.16 Billion-134.07%
2022 NZ$0.45 B10.21%
2021 NZ$0.41 B12.88%
2020 NZ$0.36 B-657.8%
2019 -NZ$65.42 Million-143.45%
2018 NZ$0.15 B-50.46%
2017 NZ$0.30 B52.98%
2016 NZ$0.19 B-31.39%
2015 NZ$0.28 B45.68%
2014 NZ$0.19 B10.59%
2013 NZ$0.17 B38.24%
2012 NZ$0.13 B8.79%
2011 NZ$0.11 B55.18%
2010 NZ$77 M-123.77%
2009 -NZ$0.33 Billion-446.47%
2008 NZ$93.5 M8.03%
2007 NZ$86.56 M-3.71%
2006 NZ$89.89 M42.33%
2005 NZ$63.15 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.13 B 12,481.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$36.58 B 7,955.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.84 B 6,031.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.35 B 3,721.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.41 B 3,074.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$1.67 B 269.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$8.94 B 1,870.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.85 B 3,610.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-NZ$2.37 Billion-621.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$74.46 M-83.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel